Sage Journals: Discover world-class research

Open access

Review article

First published 2023

Advances in the management of non-small-cell lung cancer harbouring EGFR exon 20 insertion mutations

Jia Li Low, Sun Min Lim, Jii Bum Lee [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025-1

The combination of immune checkpoint inhibitor and chemotherapy may be efficacious for advanced non-small cell lung cancer with near-loop insertions of EGFR exon 20: A retrospective analysis

Ke-Jun Liu, Hong-Rui Li, Quan-Quan Tan [...]

Science Progress

Open access

Research article

First published 2024-06

Evaluating the Clinical Characteristics and Prognosis of Advanced Non-Small Cell Lung Cancer with Exon 20 Insertions

Haibo Wang, Yiquan Xu, Jinlan Lin [...]

Cancer Control

Retricted access

Case report

First published 2020-1

Treatment exceeds expectations in a patient with non-small cell lung adenocarcinoma with an EGFR exon 20 mutation

Agnes McAuliffe, Poorva Bindal, Meredith Haley [...]

Journal of Oncology Pharmacy Practice

Retricted access

Article commentary

First published 2021-12

Positive progress for non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: A novel targeted therapy option

Weisan Zhang, Xifeng Dong

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2023-6

New therapies in non-small cell lung cancer with EGFR exon 20 insertion mutations

Gil-Sierra Manuel David, Briceño-Casado Maria del Pilar, Moreno-Ramos Cristina

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2024-10

Targeting EGFR Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer: Changes in Treatment Strategies are Coming

Haoli Liu, Jing Qin, Xinyu Qian

Cancer Control

Open access

Review article

First published 2021

Current and future treatment options for MET exon 14 skipping alterations in non-small cell lung cancer

Lingzhi Hong, Jianjun Zhang, John V. Heymach [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2023-2

Targeting EGFR Exon 20 Insertion Mutation in Non–small cell Lung Cancer: Amivantamab and Mobocertinib

Molly C. Russell, Alyssa M. Garelli, David J. Reeves

Annals of Pharmacotherapy

Retricted access

Case report

First published 2024-12

A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome

Valeria Cognigni, Enrica Capelletto, Paola Bordi [...]

Tumori Journal

Search results